UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000010869
Receipt No. R000012560
Scientific Title Phase II trial of trasutuzumab plus docetaxel for previous trastuzumab treated unresectable or recurrent HER2 positive gastric cancer (T-CORE1203)
Date of disclosure of the study information 2013/06/06
Last modified on 2020/07/07 15:22:31

No. Disposal Last modified on Item of update
1 Insert 2013/06/04 15:33:16
2 Update 2013/12/05 12:45:38 TEL
Email
Last name of contact person
Last name of contact person
3 Update 2014/12/05 08:56:15 Anticipated trial start date
4 Update 2014/12/05 08:57:06 Anticipated trial start date
5 Update 2015/12/10 14:39:49 Anticipated trial start date
6 Update 2016/01/05 09:21:32 Email
7 Update 2016/12/06 13:47:18 Recruitment status
8 Update 2019/02/18 15:15:20 Last name of lead principal investigator
Last name of lead principal investigator
Organization
Organization
Division name
Division name
Address
Address
TEL
Email
Last name of contact person
Last name of contact person
Email
Name of primary sponsor
Institute
Organization
Organization
Organization1
Address1
Tel1
Email1
9 Update 2020/07/07 14:09:38 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code

Last name of contact person

Last name of contact person
Zip code
Organization
Organization
Address
Address
Tel
Email
10 Update 2020/07/07 14:11:19 Number of participants that the trial has enrolled
11 Update 2020/07/07 15:22:31 Recruitment status
Date of IRB
Last follow-up date


Contact us.